What is he best known for?
The fields of study he is best known for:
- Gene
- Enzyme
- Immune system
Peter F. Zipfel mostly deals with Factor H, Complement system, Alternative complement pathway, Microbiology and Molecular biology.
His Factor H study is associated with Immunology.
The concepts of his Immunology study are interwoven with issues in Genetics and Gene.
His studies deal with areas such as Platelet, Innate immune system and Endocrinology as well as Complement system.
As part of the same scientific family, Peter F. Zipfel usually focuses on Alternative complement pathway, concentrating on Biochemistry and intersecting with Candida albicans.
His Microbiology research integrates issues from Virulence factor, Borrelia burgdorferi, Immune system and Binding site.
His most cited work include:
- Complement Resistance of Borrelia burgdorferi Correlates with the Expression of BbCRASP-1, a Novel Linear Plasmid-encoded Surface Protein That Interacts with Human Factor H and FHL-1 and Is Unrelated to Erp Proteins (207 citations)
- Anti–factor H autoantibodies block C-terminal recognition function of factor H in hemolytic uremic syndrome (194 citations)
- Anti–factor H autoantibodies block C-terminal recognition function of factor H in hemolytic uremic syndrome (194 citations)
What are the main themes of his work throughout his whole career to date?
The scientist’s investigation covers issues in Factor H, Complement system, Microbiology, Immunology and Alternative complement pathway.
His Factor H study integrates concerns from other disciplines, such as Complement factor I, Molecular biology and Cell biology.
As a part of the same scientific family, he mostly works in the field of Cell biology, focusing on Complement and, on occasion, Regulator.
In most of his Complement system studies, his work intersects topics such as Plasma protein binding.
His research integrates issues of Plasmin, Innate immune system, Immune system and Borrelia burgdorferi in his study of Microbiology.
The Immunology study combines topics in areas such as Internal medicine and Disease.
He most often published in these fields:
- Factor H (58.56%)
- Complement system (57.00%)
- Microbiology (51.95%)
What were the highlights of his more recent work (between 2015-2021)?
- Complement system (57.00%)
- Immune system (26.46%)
- Microbiology (51.95%)
In recent papers he was focusing on the following fields of study:
His primary areas of investigation include Complement system, Immune system, Microbiology, Immunology and Cell biology.
His research related to Factor H, Alternative complement pathway, Complement inhibitor and Complement factor I might be considered part of Complement system.
Peter F. Zipfel studies Factor H, focusing on CFHR5 in particular.
His Immune system study combines topics from a wide range of disciplines, such as Virology, Gene, Borrelia miyamotoi and Candida albicans.
The study incorporates disciplines such as Receptor, Plasma protein binding, Vitronectin and Plasmin in addition to Microbiology.
His work in Immunology tackles topics such as Glomerulopathy which are related to areas like Transplantation, Membranoproliferative glomerulonephritis, Atypical hemolytic uremic syndrome and Vasculitis.
Between 2015 and 2021, his most popular works were:
- ApoE attenuates unresolvable inflammation by complex formation with activated C1q (86 citations)
- ApoE attenuates unresolvable inflammation by complex formation with activated C1q (86 citations)
- C3 glomerulopathy — understanding a rare complement-driven renal disease (63 citations)
In his most recent research, the most cited papers focused on:
- Gene
- Enzyme
- Immune system
His primary areas of study are Complement system, Immunology, Microbiology, Innate immune system and Alternative complement pathway.
His Complement system research is multidisciplinary, incorporating elements of Molecular biology and Microglia.
His work carried out in the field of Immunology brings together such families of science as Albuminuria and Glomerulopathy.
His biological study spans a wide range of topics, including Extracellular and Plasmin.
His Alternative complement pathway research is multidisciplinary, relying on both Recombinant DNA, Glycosylation, Glycoprotein, Disease and Pharmacology.
His Factor H research includes themes of Complement factor I, Classical complement pathway and Virology.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
